Condition: Revision Total Hip Arthroplasty · Periprosthetic Fracture of Hip · Sponsor: Aesculap AG
The study design is confirmative for non-inferiority of the functional outcome of the implants and is intended to examine the safety and performance of the Prevision hip stem. The study is an observational post-market clinical follow-up study, and the study sites chose the stem variant depending on their own routine and indication.
This description comes directly from the study's public registry record.
Kerstin Bergmann · +49746195- · studies@aesculap.de
Lutz Dreyer, Dr. · +49746195- · studies@aesculap.de
Always discuss trial participation with your own doctor first.
| Orthopädische Kliniken im Annastift, MHH, Anna-von-Borries-Str. 1-7 | Hanover, Germany | Recruiting |
| Hinchingbrooke Hospital | Huntingdon, Cambridgeshire, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06626490